S&P 500 · sector · 60 companies
Health Care stocks in the S&P 500
In their latest fiscal years the companies of the sector had combined revenue of $3.66T and net income of $196B (5.4% of revenue). The largest by revenue is UnitedHealth Group.
Combined revenue in the latest fiscal year, 60 companies
$3.66T+9.1% a year
median revenue growth over 10 years (53 companies)
Companies
60
sub-industries: 10
Combined net income
$196B
5.4% of revenue
Median net margin
13.0%
latest fiscal year
Pay a dividend
37 of 60
raised it every year in the data: 7 companies
Fewer shares than 10 years ago
31 of 57
median change −5.8%
Combined revenue and net income since 2010
Revenue of the companies with figures for every year (48) went from $980B in 2010 to $3.33T in 2025, 8.5% a year.
RevenueNet income
The chart data could not be loaded. The table below has the same figures.
Companies
| UnitedHealth Group | UNH | Managed Health Care | 2025 | $448B | $12.1B | 2.7% | 11.7% | 11.0% | 8.2% | $8.73 | 16 | −5.8% |
| McKesson | MCK | Health Care Distributors | 2026 | $403B | $4.76B | 1.2% | 11.1% | 7.8% | 14.7% | $3.17 | 13 | −46.7% |
| CVS Health | CVS | Health Care Services | 2025 | $402B | $1.77B | 0.4% | 8.4% | 10.1% | −11.3% | $2.66 | 0 | +12.9% |
| Cencora | COR | Health Care Distributors | 2025 | $321B | $1.55B | 0.5% | 11.1% | 9.0% | — | $2.20 | 17+ | −10.4% |
| Cigna | CI | Health Care Services | 2025 | $275B | $5.96B | 2.2% | 11.4% | 21.9% | 10.7% | $6.04 | 5 | +3.1% |
| Cardinal Health | CAH | Health Care Distributors | 2026 | $254B | $1.71B | 0.7% | 9.4% | 7.7% | 5.3% | $2.04 | 18+ | −28.2% |
| Elevance Health | ELV | Managed Health Care | 2025 | $199B | $5.66B | 2.8% | 10.3% | 9.7% | 10.4% | $6.84 | 14 | −17.7% |
| Centene Corporation | CNC | Managed Health Care | 2025 | $195B | −$6.67B | −3.4% | 11.9% | 23.9% | — | — | — | +100.3% |
| Humana | HUM | Managed Health Care | 2025 | $130B | $1.19B | 0.9% | 10.9% | 9.1% | 1.5% | $3.54 | 0 | −20.1% |
| Johnson & Johnson | JNJ | Pharmaceuticals | 2025 | $94.2B | $26.8B | 28.5% | 2.7% | 3.0% | 7.2% | $5.14 | 18+ | −13.6% |
| HCA Healthcare | HCA | Health Care Facilities | 2025 | $75.6B | $6.78B | 9.0% | 8.0% | — | 19.0% | $2.88 | 5 | −43.9% |
| Lilly (Eli) | LLY | Pharmaceuticals | 2025 | $65.2B | $20.6B | 31.7% | 21.6% | 12.6% | 26.1% | $6.23 | 9 | −15.6% |
| Merck & Co. | MRK | Pharmaceuticals | 2025 | $65B | $18.3B | 28.1% | 9.4% | 5.1% | 16.7% | $3.28 | 15 | −11.8% |
| Pfizer | PFE | Pharmaceuticals | 2025 | $62.6B | $7.77B | 12.4% | 8.5% | 2.5% | 2.1% | $1.72 | 15 | −8.7% |
| AbbVie | ABBV | Biotechnology | 2025 | $61.2B | $4.23B | 6.9% | 6.0% | 10.3% | −2.8% | $6.65 | 11 | +8.3% |
| Bristol Myers Squibb | BMY | Pharmaceuticals | 2025 | $48.2B | $7.05B | 14.6% | 2.5% | 11.3% | 14.0% | $2.49 | 18+ | +21.4% |
| Thermo Fisher Scientific | TMO | Life Sciences Tools & Services | 2025 | $44.6B | $6.7B | 15.0% | 6.7% | 10.1% | 13.7% | $1.72 | 8 | −6.0% |
| Abbott Laboratories | ABT | Health Care Equipment | 2025 | $44.3B | $6.52B | 14.7% | 5.1% | 8.1% | 2.5% | $2.40 | 3 | +16.1% |
| Amgen | AMGN | Biotechnology | 2025 | $36.8B | $7.71B | 21.0% | 7.6% | 5.4% | 4.6% | $9.66 | 12 | −29.2% |
| Medtronic | MDT | Health Care Equipment | 2026 | $36.4B | $4.8B | 13.2% | 3.8% | 2.3% | 4.2% | $2.84 | 18+ | −9.7% |
| Gilead Sciences | GILD | Biotechnology | 2025 | $29.4B | $8.51B | 28.9% | 3.6% | −1.0% | −5.5% | $3.16 | 10 | −17.5% |
| Stryker Corporation | SYK | Health Care Equipment | 2025 | $25.1B | $3.25B | 12.9% | 11.8% | 9.7% | 8.3% | $3.40 | 16 | +1.5% |
| Danaher Corporation | DHR | Life Sciences Tools & Services | 2025 | $24.6B | $3.61B | 14.7% | 2.0% | — | 0.6% | — | — | +1.1% |
| Becton Dickinson | BDX | Health Care Equipment | 2025 | $21.8B | $1.68B | 7.7% | 6.3% | 7.8% | 5.7% | $4.16 | 12 | +39.0% |
| GE HealthCare | GEHC | Health Care Equipment | 2025 | $20.6B | $2.08B | 10.1% | — | — | — | $0.14 | 2+ | — |
| Boston Scientific | BSX | Health Care Equipment | 2025 | $20.1B | $2.9B | 14.4% | 15.2% | 9.5% | — | — | — | +11.4% |
| Universal Health Services | UHS | Health Care Facilities | 2025 | $17.4B | $1.49B | 8.6% | 8.5% | 6.7% | 13.1% | $0.80 | 0 | −36.0% |
| IQVIA | IQV | Life Sciences Tools & Services | 2025 | $16.3B | $1.36B | 8.3% | 7.5% | 11.0% | 9.8% | — | — | +38.1% |
| Regeneron Pharmaceuticals | REGN | Biotechnology | 2025 | $14.3B | $4.5B | 31.4% | 11.0% | 13.3% | 22.3% | $3.52 | 0 | −5.8% |
| Viatris | VTRS | Pharmaceuticals | 2025 | $14.3B | −$3.51B | −24.6% | 3.7% | 4.3% | — | $0.48 | 0 | +134.6% |
| Labcorp | LH | Health Care Services | 2025 | $14B | $876M | 6.3% | −0.0% | 4.9% | 9.2% | $2.88 | 0 | −16.7% |
| DaVita | DVA | Health Care Services | 2025 | $13.6B | $747M | 5.5% | 3.4% | — | 22.9% | — | — | −64.9% |
| Henry Schein | HSIC | Health Care Distributors | 2025 | $13.2B | $398M | 3.0% | 5.4% | — | 1.4% | — | — | −27.7% |
| Vertex Pharmaceuticals | VRTX | Biotechnology | 2025 | $12B | $3.95B | 32.9% | 14.1% | 27.8% | — | — | — | +6.9% |
| Baxter International | BAX | Health Care Equipment | 2025 | $11.2B | −$957M | −8.5% | −0.7% | 1.2% | — | $0.52 | 0 | −6.6% |
| Quest Diagnostics | DGX | Health Care Services | 2025 | $11B | $992M | 9.0% | 3.2% | 3.9% | 6.0% | $3.20 | 15 | −22.1% |
| Intuitive Surgical | ISRG | Health Care Equipment | 2025 | $10.1B | $2.86B | 28.4% | 18.2% | 15.5% | 16.4% | — | — | +6.3% |
| Biogen | BIIB | Biotechnology | 2025 | $9.89B | $1.29B | 13.1% | −6.0% | −0.8% | −5.4% | — | — | −36.4% |
| Zoetis | ZTS | Pharmaceuticals | 2025 | $9.47B | $2.67B | 28.2% | 7.2% | 7.1% | 24.4% | $2.03 | 12 | −11.6% |
| Solventum | SOLV | Health Care Technology | 2025 | $8.32B | $1.56B | 18.7% | — | — | — | — | — | — |
| Zimmer Biomet | ZBH | Health Care Equipment | 2025 | $8.23B | $705M | 8.6% | 6.1% | 3.2% | 16.5% | $0.96 | 0 | +4.7% |
| Agilent Technologies | A | Life Sciences Tools & Services | 2025 | $6.95B | $1.3B | 18.8% | 5.4% | 5.6% | 14.3% | $0.99 | 10 | −14.9% |
| Edwards Lifesciences | EW | Health Care Equipment | 2025 | $6.07B | $1.07B | 17.7% | 6.7% | 9.3% | 9.3% | — | — | −11.4% |
| Steris | STE | Health Care Equipment | 2026 | $5.94B | $782M | 13.2% | 13.8% | 10.2% | 17.7% | $2.46 | 15 | +38.7% |
| ResMed | RMD | Health Care Equipment | 2026 | $5.65B | $1.52B | 26.9% | 12.1% | 11.9% | 15.4% | $2.40 | 5 | +3.1% |
| Incyte | INCY | Biotechnology | 2025 | $5.14B | $1.29B | 25.0% | 14.0% | 21.2% | 71.0% | — | — | +7.2% |
| Dexcom | DXCM | Health Care Equipment | 2025 | $4.66B | $836M | 17.9% | 19.3% | 27.8% | — | — | — | +27.0% |
| Illumina, Inc. | ILMN | Life Sciences Tools & Services | 2025 | $4.34B | $850M | 19.6% | 6.0% | 6.9% | 5.8% | — | — | +4.7% |
| Idexx Laboratories | IDXX | Health Care Equipment | 2025 | $4.3B | $1.06B | 24.6% | 9.7% | 10.4% | 20.4% | — | — | −13.5% |
| Cooper Companies (The) | COO | Health Care Supplies | 2025 | $4.09B | $375M | 9.2% | 11.0% | 8.6% | 6.1% | — | — | +1.6% |
| Align Technology | ALGN | Health Care Supplies | 2025 | $4.03B | $410M | 10.2% | 10.3% | 16.9% | 12.3% | — | — | −11.0% |
| Mettler Toledo | MTD | Life Sciences Tools & Services | 2025 | $4.03B | $869M | 21.6% | 5.5% | 5.3% | 12.9% | — | — | −26.9% |
| Charles River Laboratories | CRL | Life Sciences Tools & Services | 2025 | $4.02B | −$144M | −3.6% | 6.5% | 11.4% | — | — | — | +4.1% |
| Veeva Systems | VEEV | Health Care Technology | 2026 | $3.2B | $909M | 28.4% | 16.9% | 22.8% | 30.5% | — | — | +15.2% |
| Waters Corporation | WAT | Life Sciences Tools & Services | 2025 | $3.17B | $643M | 20.3% | 6.0% | 4.5% | 6.7% | — | — | −28.1% |
| West Pharmaceutical Services | WST | Health Care Supplies | 2025 | $3.07B | $494M | 16.1% | 7.4% | 8.2% | 18.0% | $0.86 | 17+ | −1.5% |
| Revvity | RVTY | Health Care Equipment | 2025 | $2.86B | $241M | 8.4% | 1.4% | 3.1% | 1.0% | $0.28 | 0 | +2.9% |
| Insulet Corporation | PODD | Health Care Equipment | 2025 | $2.71B | $247M | 9.1% | 24.5% | 26.2% | — | — | — | +26.6% |
| Moderna | MRNA | Biotechnology | 2025 | $1.94B | −$2.82B | −145.2% | 19.3% | — | — | — | — | — |
| Bio-Techne | TECH | Life Sciences Tools & Services | 2026 | $1.22B | $182M | 15.0% | 5.5% | 9.3% | 5.2% | $0.32 | 0 | +5.2% |
Revenue and net income: the latest full fiscal year (FY). Growth: average annual rate over 5 or 10 years. Dividend: per share in the latest year. Raises in a row: consecutive years of a higher dividend per share; the SEC data start in 2009 (with 2007–2008 as comparison years), so + marks a run that goes back to where the company’s figures begin. Shares, 10 yrs: change in the number of shares; below zero means buybacks. —: not in the data or not meaningful.
Other sectors
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.